Valuation : Implantica AG

Market Cap 1.53B 1.77B 1.43B 1.31B 2.46B 170B 2.47B 17B 6.63B 85.58B 6.66B 6.51B 284B P/E 2026 *
-18x
P/E 2027 * -14.6x
Enterprise Value 1.5B 1.74B 1.41B 1.28B 2.42B 166B 2.43B 16.69B 6.51B 84.01B 6.54B 6.4B 279B EV / Sales 2026 *
441x
EV / Sales 2027 * 168x
Free-Float
-
Yield 2026 *
-
Yield 2027 * -
1 day+0.67%
1 week+6.19%
Current month-2.91%
1 month+3.09%
3 months-3.85%
6 months+30.43%
Current year+19.76%
1 week 53.2
Extreme 53.2
63
1 month 50.8
Extreme 50.8
80.3
Current year 38
Extreme 38
80.3
1 year 38
Extreme 38
80.3
3 years 16
Extreme 16
86.4
5 years 15.4
Extreme 15.4
115
10 years 15.4
Extreme 15.4
178.9
Manager TitleAgeSince
Chief Executive Officer 72 2014-12-31
Director of Finance/CFO 48 2019-12-31
Corporate Officer/Principal 69 -
Director TitleAgeSince
Chairman 67 2019-12-31
Director/Board Member 62 2019-12-31
Director/Board Member 71 2019-12-31
Date Insider Type Main position Quantity % Market Cap.
3/31/26 Buy

Chairman

28,135 0.0484%
9/24/25 Sell

Chief Financial Officer

16,700 0.0287%
9/24/25 Sell

Chief Financial Officer

17,100 0.0294%
Change 5-day change 1-year change 3-year change Capi.($)
+0.67%+6.19%-17.70%+138.57% 1.77B
+0.21%-1.08%+18.40%+27.38% 12.67B
+0.81%+1.27%+19.98%+29.02% 7.03B
-1.35%-5.76%+51.37%+28.91% 6.32B
+3.02%-1.71% - - 5.64B
-0.97%-5.83%-12.90%+58.10% 5.14B
-0.30%+3.22%-28.81%-21.57% 3.89B
-0.94%+4.21%+48.19%-4.22% 2.08B
+0.32%+4.79%+51.05%-11.31% 1.65B
+0.50%+3.41%-3.54%+18.59% 1.36B
Average +0.20%+0.84%+14.01%+29.27% 4.76B
Weighted average by Cap. +0.23%-0.73%+15.94%+28.44%

Financials

2026 *2027 *
Net sales 3.4M 3.95M 3.19M 2.91M 5.48M 377M 5.5M 37.82M 14.76M 190M 14.81M 14.49M 631M 9.1M 10.56M 8.53M 7.79M 14.67M 1.01B 14.72M 101M 39.5M 509M 39.65M 38.79M 1.69B
Net income -21M -24.37M -19.69M -17.97M -33.86M -2.33B -33.97M -234M -91.14M -1.18B -91.5M -89.51M -3.9B -26M -30.17M -24.38M -22.25M -41.92M -2.88B -42.06M -289M -113M -1.46B -113M -111M -4.83B
Net Debt -28M -32.49M -26.25M -23.96M -45.15M -3.11B -45.29M -311M -122M -1.57B -122M -119M -5.2B -2M -2.32M -1.88M -1.71M -3.22M -222M -3.24M -22.25M -8.68M -112M -8.71M -8.52M -371M
Logo Implantica AG
Implantica AG is Lichtenstein-based medical technology Company, whose mission is to provide effective treatment for serious health conditions and to improve patients' life through the use of advanced technologies in the human body, ultimately aiming to reduce costs and increase efficiency in the healthcare System. The therapies developed by Implantica are based on implants that are inserted into the patient's body and remain in the body permanently or semi-permanently to replace bodily functions and/or treat diseases. The Company focuses on the discovery, development and prospective commercialization of medical products and implants that are intended for use in different treatment fields like in the area of gastrointestinal surgery and urology. The Company's lead product is RefluxStop, a passive, implant to prevent gastroesophageal reflux disease (GERD).
Employees
-
Date Price Change Volume
26-08-28 SEK 60.00 +0.67% 45,211
26-08-27 SEK 59.60 -5.10% 60,090
26-08-26 SEK 62.80 +8.28% 188,530
26-08-25 SEK 58.00 +7.01% 113,005
26-08-24 SEK 54.20 -4.07% 426,573
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
5.394EUR
Average target price
8.141EUR
Spread / Average Target
+50.93%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IMP A SDB Stock